GSK - Long -TGT 2482GSK stock has been strengthening. for the last periods.
The stock is expected to hit the levels of 2482 as per the technical analysis.
The stock has already hit the support levels at 1825. Its expected to blast out of the triangle and move higher. However , the stock has goos support at the levels o
GSK plc
No trades
No trades
Peers for comparison
Key facts today
1.0 GBP
5.72 B GBP
32.67 B GBP
3.89 B
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Luke Victor Miels
Website
Headquarters
London
IPO date
May 22, 1972
ISIN
GB00BN7SWP63
FIGI
BBG000CT5GJ1
Identifiers
ISIN GB00BN7SWP63
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
GSK | Powerful Move Going Into 2026 | LONGGSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three prod
GSK 1-2 wk swing IdeaNYSE:GSK has set of a daily trigger with a 5/10 ema crossover after a positive earnings report.
During my planning for this idea, I needed to zoom WAY out to the monthly chart in order to understand these levels a bit more. Screen shot of the monthly below:
It turns out that last week's close
GSK (GSK) Outperformed Market ReturnsIn the latest trading session, GSK (GSK) closed at $37.10, marking a +1.23% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq added 0.39%.
Prior to today's trading, shares of the dru
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateApr 10, 2042
Coupon5.25% (Fixed)
Maturity dateSep 15, 2056
Coupon6.00% (Fixed)
Maturity dateMar 18, 2043
Coupon4.20% (Fixed)
Maturity dateMar 9, 2039
Coupon6.38% (Fixed)
Maturity dateMay 15, 2038
Coupon6.38% (Fixed)
Maturity dateMay 12, 2035
Coupon1.63% (Fixed)
Maturity dateSep 15, 2036
Coupon5.50% (Fixed)
Maturity dateApr 15, 2035
Coupon4.88% (Fixed)
Maturity dateDec 18, 2045
Coupon4.25% (Fixed)
Maturity dateSep 15, 2033
Coupon5.25% (Fixed)
See all GSK bonds
Frequently asked questions
Today, GSK trades at 1,908.0 GBX.
For broader market analysis, dive into the technicals on the GSK plc stock price chart and read the latest GSK news:
– GSK Announces Bexsero Booster Receives Positive CHMP Opinion
– REG - GSK PLC - Bexsero booster receives positive CHMP opinion
– REG - GSK PLC - Director/PDMR Shareholding
For broader market analysis, dive into the technicals on the GSK plc stock price chart and read the latest GSK news:
– GSK Announces Bexsero Booster Receives Positive CHMP Opinion
– REG - GSK PLC - Bexsero booster receives positive CHMP opinion
– REG - GSK PLC - Director/PDMR Shareholding
Markets don't sleep, here's what's going on with GSK at the moment:
– GSK Announces Bexsero Booster Receives Positive CHMP Opinion
– REG - GSK PLC - Bexsero booster receives positive CHMP opinion
– REG - GSK PLC - Director/PDMR Shareholding
See more updates in real-time with our News Flow.
– GSK Announces Bexsero Booster Receives Positive CHMP Opinion
– REG - GSK PLC - Bexsero booster receives positive CHMP opinion
– REG - GSK PLC - Director/PDMR Shareholding
See more updates in real-time with our News Flow.
GSK plc is scheduled to release its next earnings report on Feb 3, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
GSK stock is 0.74% volatile and has beta coefficient of 1.27.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like GSK are typically less volatile than smaller companies
Track every detail on GSK plc stock chart and check out the list of the most volatile stocks — is GSK plc there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like GSK are typically less volatile than smaller companies
Track every detail on GSK plc stock chart and check out the list of the most volatile stocks — is GSK plc there?
To understand the GSK stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +1.14%
– 1 week — +0.18%
– 1 month — +6.20%
GSK all-time low was 740.5 GBX (Sep 22, 1995), and its highest price is 2,356.5 GBX (Jan 8, 1999). Find more dynamics in the Stock Heatmap and on the GSK plc stock chart.
– 1 day — +1.14%
– 1 week — +0.18%
– 1 month — +6.20%
GSK all-time low was 740.5 GBX (Sep 22, 1995), and its highest price is 2,356.5 GBX (Jan 8, 1999). Find more dynamics in the Stock Heatmap and on the GSK plc stock chart.
GSK plc market capitalization is 75.65 B, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from GSK plc stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how GSK plc stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from GSK plc stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how GSK plc stacks up against other companies
The safest way to buy GSK plc stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade GSK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade GSK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 13, 2026, the company has 66.84 K employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
GSK plc pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.
Its recent dividend yield was around 3.62%, with a payout ratio of 46.78%, compared to 4.53% and 96.58% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in GSK plc financials.
Its recent dividend yield was around 3.62%, with a payout ratio of 46.78%, compared to 4.53% and 96.58% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in GSK plc financials.
Investing in GSK plc depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study GSK plc financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our GSK technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
First, study GSK plc financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our GSK technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
GSK plc stock ticker depends on the exchange where it’s listed. On the LSE, its primary exchange, GSK plc stocks trade under the symbol GSK.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
GSK earnings for the last quarter are 0.55 GBX per share, whereas the estimation was 0.50 GBX, resulting in a 8.46% surprise. The estimated earnings for the next quarter are 0.28 GBX per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in GSK plc financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in GSK plc financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
GSK plc revenue for the last quarter amounts to 8.89 B GBX despite the estimated figure of 8.86 B GBX. In the next quarter revenue is expected to reach 8.84 B GBX.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in GSK plc financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in GSK plc financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track GSK plc financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
GSK net income for the last quarter is 1.54 B GBP, while the quarter before that showed 435.00 M GBP of net income which accounts for 254.71% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in GSK plc financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in GSK plc financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
GSK plc does pay dividends, which are distributed quarterly. The most recent dividend per share was 0.17 GBP, with a trailing twelve-month (TTM) dividend yield of 3.60%.
Explore more details on GSK plc dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
Explore more details on GSK plc dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
GSK reached its all-time high of 2,356.5 GBX on Jan 8, 1999. Its all-time low was 740.5 GBX and was reached on Sep 22, 1995.
Explore the GSK plc stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the GSK plc stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
GSK plc EBITDA is 10.51 B GBP, with an EBITDA margin of 32.24%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in GSK plc statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in GSK plc statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 1,700.00 GBX and 3,004.00 GBX for GSK, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance









